Gideon M. Hirschfield spends much of his time researching Internal medicine, Primary biliary cirrhosis, Immunology, Gastroenterology and Primary sclerosing cholangitis. In his research, Predictive value of tests and Clinical trial is intimately related to Surgery, which falls under the overarching field of Internal medicine. His Primary biliary cirrhosis study combines topics from a wide range of disciplines, such as Genome-wide association study, Autoantibody, Antibody, Cirrhosis and Genotype.
Immunology is often connected to Disease in his work. His Primary sclerosing cholangitis study combines topics in areas such as Autoimmune hepatitis, Liver biopsy and Ulcerative colitis. The concepts of his C-reactive protein study are interwoven with issues in Myocardial infarction and Acute-phase protein.
Internal medicine, Gastroenterology, Primary sclerosing cholangitis, Primary biliary cirrhosis and Immunology are his primary areas of study. His work on Ursodeoxycholic acid, Liver transplantation, Cirrhosis and Cohort is typically connected to In patient as part of general Internal medicine study, connecting several disciplines of science. His Liver transplantation research includes themes of Colectomy, Proportional hazards model and Hazard ratio.
As part of his studies on Gastroenterology, Gideon M. Hirschfield often connects relevant areas like Obeticholic acid. He has included themes like Colitis, Inflammatory bowel disease, Pediatrics and Ulcerative colitis in his Primary sclerosing cholangitis study. The study incorporates disciplines such as Genome-wide association study and Disease in addition to Primary biliary cirrhosis.
Gideon M. Hirschfield mainly investigates Internal medicine, Gastroenterology, Primary sclerosing cholangitis, Liver transplantation and Ursodeoxycholic acid. While working in this field, Gideon M. Hirschfield studies both Internal medicine and In patient. His work carried out in the field of Gastroenterology brings together such families of science as Proportional hazards model, Autoimmune hepatitis, Clinical trial and Obeticholic acid.
His work deals with themes such as Crohn's disease, Incidence, Radiology and Inflammatory bowel disease, which intersect with Primary sclerosing cholangitis. His research investigates the connection with Liver transplantation and areas like Liver disease which intersect with concerns in Steatohepatitis. His Ursodeoxycholic acid research is multidisciplinary, incorporating elements of Budesonide, Phases of clinical research, Primary biliary cirrhosis, Bile acid and Clinical endpoint.
Gideon M. Hirschfield mostly deals with Internal medicine, Gastroenterology, Primary sclerosing cholangitis, Liver transplantation and Cholestasis. His research related to Hazard ratio, Proportional hazards model, Ursodeoxycholic acid, Interquartile range and Cohort might be considered part of Internal medicine. His Gastroenterology study combines topics in areas such as Retrospective cohort study, Autoimmune hepatitis and Bile acid.
Primary sclerosing cholangitis is the subject of his research, which falls under Pathology. His research on Cholestasis also deals with topics like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
C-reactive protein: a critical update
Mark B. Pepys;Gideon M. Hirschfield.
Journal of Clinical Investigation (2003)
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease
John Danesh;Jeremy G. Wheeler;Gideon M. Hirschfield;Shinichi Eda.
The New England Journal of Medicine (2004)
The gut microbiota and host health: a new clinical frontier
Julian Roberto Marchesi;David H. Adams;Francesca Fava;Gerben D. A. Hermes.
Targeting C-reactive protein for the treatment of cardiovascular disease
Mark B Pepys;Gideon M Hirschfield;Glenys A Tennent;J Ruth Gallimore.
A Placebo-controlled trial of obeticholic acid in primary biliary cholangitis
F. Nevens;P. Andreone;G. Mazzella;S. I. Strasser.
The New England Journal of Medicine (2016)
Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants.
Gideon M. Hirschfield;Xiangdong Liu;Chun Xu;Yue Lu.
The New England Journal of Medicine (2009)
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
Gideon M. Hirschfield;Ulrich Beuers;Christophe Corpechot;Pietro Invernizzi.
Journal of Hepatology (2017)
Primary sclerosing cholangitis
Gideon M Hirschfield;Tom H Karlsen;Tom H Karlsen;Keith D Lindor;David H Adams.
The Lancet (2013)
Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid
Gideon M. Hirschfield;Andrew Mason;Velimir Luketic;Velimir Luketic;Keith Lindor;Keith Lindor.
Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma.
John C Chambers;John C Chambers;John C Chambers;Weihua Zhang;Weihua Zhang;Joban S. Sehmi;Joban S. Sehmi;Xinzhong Li.
Nature Genetics (2011)
Journal of Hepatology
(Impact Factor: 30.083)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: